KLICHINSKY MICHAEL (Chief Scientific Officer) sold 56.98K shares of CARISMA THERAPEUTICS INC. on the open market
Open‑market sale worth $14.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/8/2025ACC: 0001104659-25-097928
Officer· Chief Scientific Officer
Since Mar 2023
-56.98K
Net shares
Net seller
$14.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
56.98K acquired · 113.96K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+56.98K
Price / share
$0.11
Trade value
$6.27K
% of position
New position
10/7/2025
0.00→56.98K
Common Stock
Direct
Shares
−56.98K
Price / share
$0.25
Trade value
$14.48K
% of position
New position
10/7/2025
56.98K→0.00
Total
Net shares
+0.00
Net value
-$8.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/7/2025 | M · Option Exercise | +56.98K | $0.11 | $6.27K | New position | 0.00 | 56.98K |
| Common Stock Direct | 10/7/2025 | S · Sale | −56.98K | $0.25 | $14.48K | New position | 56.98K | 0.00 |
| Total | +0.00 | -$8.22K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
56.98K shares
Shares
−56.98K
Strike price
0.11
Held after
0.00
Exercisable
—
10/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock56.98K shares | 10/7/2025 | M · Option Exercise | −56.98K | 0.11 | — | 0.00 |